Advances in our understanding of the pathogenesis of Henoch-Schönlein purpura and the implications for improving its diagnosis

Expert Review of Clinical Immunology

Volumn 9, Issue 12, 2013, Pages 1223-1238

  Park, Se Jin ^a,b   Suh, Jin Soon ^c   Lee, Jun Ho ^d   Lee, Jung Won ^e   Kim, Seong Heon ^f   Han, Kyoung Hee ^g   Shin, Jae Il ^b  

^a Ajou University Medical Center   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d CHA University   (South Korea)

^e Hallym University   (South Korea)

^f Pusan National University School of Medicine   (South Korea)

^g Jeju National University School of Medicine   (South Korea)

Author keywords

Cytokines; Diagnosis; Genetic susceptibility; Henoch Sch nlein purpura; Immunoglobulins; Pathogenesis; Vasculitis

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; CHEMOKINE; COMPLEMENT; CYCLOPHOSPHAMIDE; CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ANAPHYLACTOID PURPURA; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CELL ACTIVATION; ENDOTHELIUM INJURY; EOSINOPHIL; GENETIC PREDISPOSITION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MEDICAL SOCIETY; NONHUMAN; PATHOGENESIS; PROTEIN GLYCOSYLATION; REVIEW;

ANIMALS; AUTOANTIBODIES; BLOOD COAGULATION; COMPLEMENT ACTIVATION; CYTOKINES; EUROPE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN A; PRACTICE GUIDELINES AS TOPIC; PURPURA, SCHOENLEIN-HENOCH; UNITED STATES;

EID: 84887869986     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2013.850028     Document Type: Review

References (184)

1. Saulsbury FT. henoch-schönlein purpura. Curr. Opin. Rheumatol. 22(5), 598-602 (2010).
2. Davin JC, Weening JJ. henoch-schönlein purpura nephritis: An update. Eur. J. Pediatr. 160(12), 689-695 (2001
3. Aalberse J, Dolman K, Ramnath G, Pereira RR, Davin JC. henoch-schönlein purpura in children: An epidemiological study among Dutch paediatricians on incidence and diagnostic criteria. Ann. Rheum. Dis. 66(12), 1648-1650 (2007
4. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of henoch-schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360(9341), 1197-1202 (2002
5. Weiss PF, Klink AJ. Luan X, Feudtner C. Temporal association of Streptococcus, Staphylococcus, and parainfluenza pediatric hospitalizations and hospitalized cases of henoch-schönlein purpura. J. Rheumatol. 37(12), 2587-2594 (2010
6. Farley TA. Gillespie S, Rasoulpour M, Tolentino N, Hadler JL, Hurwitz E. Epidemiology of a cluster of henoch-schönlein purpura. Am. J. Dis. Child. 143(7), 798-803 (1989
7. Borras-Blasco J, Enriquez R, Amoros F et al. henoch-schönlein purpura associated with clarithromycin. Case report and review of literature. Int. J. Clin. Pharmacol. Ther. 41(5), 213-216 (2003
8. Spyridis N. Salapata M, Fessatou S, Kontaxaki C, Spyridis P. Simultaneous presentation of henoch-schönlein purpura in monozygotic twins. Scand. J. Infect. Dis. 37(9), 703-704 (2005
9. Motoyama O. Iitaka K. Familial cases of henoch-schönlein purpura in eight families. Pediatr. Int. 47(6), 612-615 (2005
10. Shin JI, Lee JS. Familial clusturing of henoch-schönlein purpura or IgA nephropathy: Genetic background or environmental triggers? Pediatr. Dermatol. 25(6), 651 (2008
11. Zhang Y. Gu W, Mao J. Sibling cases of henoch-schönlein purpura in two families and review of literature. Pediatr. Dermatol. 25(3), 393-395 (2008
12. Soylemezoglu O. Peru H, Gonen S, Cetinyurek A, Buyan N. HLA-DRB1 alleles and henoch-schönlein purpura: Susceptibility and severity of disease. J. Rheumatol. 35(6), 1165-1168 (2008
13. Soylemezoglu O, Peru H, Gonen S et al. CTLA-4 +49 A/G genotype and HLA-DRB1 polymorphisms in Turkish patients with henoch-schönlein purpura. Pediatr. Nephrol. 23(8), 1239-1244 (2008
14. Amoli MM, Thomson W, Hajeer AH et al. HLA-B35 association with nephritis in henoch-schönlein purpura. J. Rheumatol. 29(5), 948-949 (2002
15. Jin DK. Kohsaka T, Koo JW, Ha IS, Cheong HI, Choi Y. Complement 4 locus II gene deletion and DQA1 z.ast;0301 gene: Genetic risk factors for IgA nephropathy and henoch-schönlein nephritis. Nephron 73(3), 390-395 (1996
16. Ren SM, Yang GL, Liu CZ et al. Association between HLA-A and -B polymorphisms and susceptibility to henoch-schönlein purpura in Han and Mongolian children from Inner Mongolia. Genet. Mol. Res. 11(1), 221-228 (2012
17. Reiser J. Mundel P. Dual effects of RAS blockade on blood pressure and podocyte function. Curr. Hypertens. Rep. 9(5), 403-408 (2007
18. Ozkaya O, Soylemezoglu O, Gonen S et al. Renin-angiotensin system gene polymorphisms: Association with susceptibility to henoch-schönlein purpura and renal involvement. Clin. Rheumatol. 25(6), 861-865 (2006
19. Zhou TB. Ou C, Qin YH, Luo W. A meta-analysis of the association between angiotensin-converting enzyme insertion/ deletion gene polymorphism and henoch-schönlein purpura nephritis risk in Asian children. Clin. Exp. Rheumatol. 30(2), 315-316 (2012
20. Torres O. Palomino-Morales R, Miranda-Filloy JA,Vazquez-Rodriguez TR, Martin J, Gonzalez-Gay MA. IL-18 gene polymorphisms in henoch-schönlein purpura. Clin. Exp. Rheumatol. 28(1Suppl. 57), 114 (2010
21. Yang YH, Lai HJ, Kao CK, Lin YT, Chiang BL. The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with henoch-schönlein purpura. Pediatr. Nephrol. 19(9), 972-975 (2004
22. Nikibakhsh AA, Houshmand M, Bagheri M, Zadeh HM, Rad IA. MEFV gene mutations (M694V, V726A, M680I, and A744S) in Iranian children with henoch-schönlein purpura. Pneumologia 61(2), 84-87 (2012
23. Ozcakar ZB, Yalcinkaya F, Cakar N et al. MEFV mutations modify the clinical presentation of henoch-schönlein purpura. J. Rheumatol. 35(12), 2427-2429 (2008
24. He X, Lu H, Kang S et al. MEFV E148Q polymorphism is associated with henoch-schönlein purpura in Chinese children. Pediatr. Nephrol. 25(10), 2077-2082 (2010
25. Amoli MM, Thomson W, Hajeer AH et al. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in henoch-schönlein purpura. J. Rheumatol. 29(7), 1404-1407 (2002
26. Tabel Y. Mir S, Berdeli A. Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with henoch-schönlein purpura. Rheumatol. Int. 32(4), 941-947 (2012
27. Amoli MM, Calvino MC. Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA. Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in henoch-schönlein purpura. J. Rheumatol. 31(2), 295-298 (2004
28. Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc. Natl Acad. Sci. USA 92(16), 7450-7454 (1995
29. Li J. Liu H. P-selectin gene -825 polymorphism is associated with risk of henoch-schönlein purpura nephritis. Clin. Exp. Rheumatol. 29(1Suppl. 64), S134 (2011
30. Amoli MM, Mattey DL, Calvino MC et al. Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in henoch-schönlein purpura. J. Rheumatol. 28(5), 1014-1018 (2001
31. Wang JJ, Shi YP, Yue H, Chun W, Zou LP. CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric henoch-schönlein purpura. Pediatr. Nephrol. 27(11), 2059-2064 (2012
32. Martin J, Paco L, Ruiz MP et al. Inducible nitric oxide synthase polymorphism is associated with susceptibility to henoch-schönlein purpura in northwestern Spain. J. Rheumatol. 32(6), 1081-1085 (2005
33. Torres O. Palomino-Morales R, Miranda-Filloy JA, Vazquez-Rodriguez TR, Martin J, Gonzalez-Gay MA. Lack of association between toll-like receptor 4 gene polymorphism and henoch-schönlein purpura. Clin. Exp. Rheumatol. 28(1Suppl. 57), 110 (2010
34. Soylu A, Kizildag S, Kavukcu S et al. TLR-2 Arg753Gln, TLR-4 Asp299Gly, and TLR-4 Thr399Ile polymorphisms in henoch-schönlein purpura with and without renal involvement. Rheumatol. Int. 30(5), 667-670 (2010
35. Kiryluk K, Moldoveanu Z, Sanders JT et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and henoch-schönlein purpura nephritis. Kidney Int. 80(1), 79-87 (2011
36. He X, Zhao P, Kang S et al. C1GALT1 polymorphisms are associated with henoch-schönlein purpura nephritis. Pediatr. Nephrol. 27(9), 1505-1509 (2012
37. Davin JC, Ten Berge IJ, Weening JJ What is the difference between IgA nephropathy and henoch-schönlein purpura nephritis? Kidney Int. 59(3), 823-834 (2001
38. Kondo N, Kasahara K, Shinoda S, Orii T. Accelerated expression of secreted alpha-chain gene in anaphylactoid purpura. J. Clin. Immunol. 12(3), 193-196 (1992
39. De Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA. Renal involvement in henoch-schönlein purpura: A multivariate analysis of initial prognostic factors. J. Pediatr. (Rio J.) 83(3), 259-266 (2007
40. Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ, Kim HS. Serum IgA/C3 ratio may be a useful marker of disease activity in severe henoch-schönlein nephritis. Nephron Clin. Pract. 101(2), c72-c78 (2005
41. Yoo EM, Morrison SL. IgA: An immune glycoprotein. Clin. Immunol. 116(1), 3-10 (2005
42. Kerr MA. The structure and function of human IgA. Biochem. J. 271(2), 285-296 (1990
43. Renfrow MB, Mackay CL, Chalmers MJ et al. Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: Implications for IgA nephropathy. Anal. Bioanal. Chem. 389(5), 1397-1407 (2007
44. Field MC, Dwek RA, Edge CJ, Rademacher TW. O-linked oligosaccharides from human serum immunoglobulin A1. Biochem. Soc. Trans. 17(6), 1034-1035 (1989
45. Allen AC, Willis FR, Beattie TJ. Feehally J. Abnormal IgA glycosylation in henoch-schönlein purpura restricted to patients with clinical nephritis. Nephrol. Dial. Transplant. 13(4), 930-934 (1998
46. Szer IS, Pierce H. henoch-schönlein purpura. In: Rheumatology (Oxford). Hochberg MC (Ed.). Mosby/Elsevier, Philadelphia, PA, USA, 1587-1596.e1582 (2011
47. Moore JS, Kulhavy R, Tomana M et al. Reactivities of N- acetylgalactosamine-specific lectins with human IgA1 proteins. Mol. Immunol. 44(10), 2598-2604 (2007
48. Lau KK, Wyatt RJ, Moldoveanu Z et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and henoch-schönlein purpura. Pediatr. Nephrol. 22(12), 2067-2072 (2007
49. Davin JC, Pierard G, Dechenne C et al. Possible pathogenic role of IgE in henoch-schönlein purpura. Pediatr. Nephrol. 8(2), 169-171 (1994
50. He X, Li Y, Kang S et al. The CD18 AvaII polymorphic site not associated with henoch-schönlein purpura. Clin. Exp. Rheumatol. 29(1Suppl. 64), S117-S120 (2011
51. Zhang GP, Dang XQ, Yi ZW et al. Role, of mast cells in the development of renal interstitial fibrosis in children with henoch-schönlein purpura nephritis. Zhongguo Dang Dai Er Ke Za Zhi 9(2), 125-128 (2007
52. Namgoong MK, Lim BK, Kim JS. Eosinophil cationic protein in henoch-schönlein purpura and in IgA nephropathy. Pediatr. Nephrol. 11(6), 703-706 (1997
53. Kawasaki Y, Hosoya M, Suzuki H. Possible pathologenic role of interleukin-5 and eosino cationic protein in henoch-schönlein purpura nephritis. Pediatr. Int. 47(5), 512-517 (2005
54. Chen Y, Zhou JH, Wu HS, Wang HW. Role of mast cells and eosinophil cationic protein in the pathogenesis of henoch-schönlein purpura nephritis. Zhonghua Er Ke Za Zhi 44(6), 407-410 (2006
55. Faille-Kuyber EH, Kater L, Kooiker CJ, Dorhout Mees EJ. IgA-deposits in cutaneous blood-vessel walls and mesangium in henoch-schönlein syndrome. Lancet 1(7808), 892-893 (1973
56. Shulman ST, Barratt TM, Soothill JF. Immunoconglutinin and complement studies in congenital nephrotic syndrome and nephritis of henoch-schönlein purpura in children. Arch. Dis. Child. 46(250), 838-841 (1971
57. Evans DJ, Williams DG, Peters DK et al. Glomerular deposition of properdin in henoch-schönlein syndrome and idiopathic focal nephritis. Br. Med. J. 3(5875), 326-328 (1973
58. Smith MD, Barratt TM, Hayward AR, Soothill JF. The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive nephrotic syndrome and other renal diseases. Clin. Exp. Immunol. 21(2), 236-243 (1975
59. Lawrence S, Pussell BA, Charlesworth JA. Mesangial IgA nephropathy: Detection of defective reticulophagocytic function in vivo. Clin. Nephrol. 19(6), 280-283 (1983
60. Waldo FB. Is henoch-schönlein purpura the systemic form of IgA nephropathy. Am. J. Kidney Dis. 12(5), 373-377 (1988
61. Ault BH, Stapleton FB, Rivas ML et al. Association of henoch-schönlein purpura glomerulonephritis with C4B deficiency. J. Pediatr. 117(5), 753-755 (1990
62. Mclean RH, Wyatt RJ, Julian BA. Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and henoch-schönlein purpura. Kidney Int. 26(6), 855-860 (1984
63. Kawana S, Shen GH, Kobayashi Y, Nishiyama S. Membrane attack complex of complement in henoch-schönlein purpura skin and nephritis. Arch. Dermatol. Res. 282(3), 183-187 (1990
64. Bussolati B, Peri G, Salvidio G, Verzola D, Mantovani A, Camussi G. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. J. Immunol. 170(3), 1466-1472 (2003
65. Nauta AJ, Bottazzi B, Mantovani A et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur. J. Immunol. 33(2), 465-473 (2003
66. Spitzer RE, Urmson JR, Farnett ML, Stitzel AE, Post EM. Alteration of the complement system in children with henoch-schönlein purpura. Clin. Immunol. Immunopathol. 11(1), 52-59 (1978
67. Garcia-Fuentes M, Martin A, Chantler C, Williams DG. Serum complement components in henoch-schönlein purpura. Arch. Dis. Child. 53(5), 417-419 (1978
68. Levy M, Gonzalez-Burchard G, Broyer M et al. Berger's disease in children. Natural history and outcome. Medicine (Baltimore) 64(3), 157-180 (1985
69. Smith GC, Davidson JE, Hughes DA, Holme E, Beattie TJ. Complement activation in henoch-schönlein purpura. Pediatr. Nephrol. 11(4), 477-480 (1997
70. Davin JC, Vandenbroeck MC, Foidart JB, Mahieu PR. Sequential measurements of the reticulo-endothelial system function in henoch-schönlein disease of childhood. Correlations with various immunological parameters. Acta Paediatr. Scand. 74(2), 201-206 (1985
71. Endo Y. IgA nephropathy-human disease and animal model. Ren. Fail. 19(3), 347-371 (1997
72. Hisano S, Matsushita M, Fujita T, Iwasaki H. Activation of the lectin complement pathway in henoch-schönlein purpura nephritis. Am. J. Kidney Dis. 45(2), 295-302 (2005
73. Thiel S, Vorup-Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386(6624), 506-510 (1997
74. Stover CM, Thiel S, Thelen M et al. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J. Immunol. 162(6), 3481-3490 (1999
75. Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol. Rev. 180, 78-85 (2001
76. Turner MW. Mannose-binding lectin: The pluripotent molecule of the innate immune system. Immunol. Today 17(11), 532-540 (1996
77. Ogura Y, Suzuki S, Shirakawa T et al. Haemophilus parainfluenzae antigen and antibody in children with IgA nephropathy and henoch-schönlein nephritis. Am. J. Kidney Dis. 36(1), 47-52 (2000
78. Roos A, Bouwman LH, Van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167(5), 2861-2868 (2001
79. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M. Complement activation through the lectin pathway in patients with henoch-schönlein purpura nephritis. Am. J. Kidney Dis. 35(3), 401-407 (2000
80. Abou-Ragheb HH, Williams AJ, Brown CB. Milford-Ward A. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/ henoch-schönlein nephritis. Nephron 62(1), 22-26 (1992
81. Stefansson Thors V, Kolka R, Sigurdardottir SL, Edvardsson VO, Arason G, Haraldsson A. Increased frequency of C4B.*Q0 alleles in patients with henoch-schönlein purpura. Scand. J. Immunol. 61(3), 274-278 (2005
82. Islek I, Muslu A, Dagdemir A, Dilber C. Is low serum complement 3 in henoch-schönlein purpura unusual and of prognostic value. Eur. J. Pediatr. 160(6), 397-398 (2001
83. Zwirner J, Burg M, Schulze M et al. Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney Int. 51(4), 1257-1264 (1997
84. Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with henoch-schönlein purpura. Dermatology 184(3), 171-176 (1992
85. Kusunoki Y, Akutsu Y, Itami N et al. Urinary excretion of terminal complement complexes in glomerular disease. Nephron 59(1), 27-32 (1991
86. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8(4), 345-350 (2007
87. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 21(4), 467-476 (2004
88. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14(2), 155-174 (2003
89. Khoury SJ. Th17 and Treg balance in systemic sclerosis. Clin. Immunol. 139(3), 231-232 (2011
90. Ziegler SF. FOXP3: Not just for regulatory T cells anymore. Eur. J. Immunol. 37(1), 21-23 (2007
91. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117(3), 289-300 (2006
92. Chen O, Zhu XB, Ren H, Wang YB, Sun R. The imbalance of Th17/Treg in Chinese children with henoch-schönlein purpura. Int. Immunopharmacol. 16(1), 67-71 (2013
93. Li YY, Li CR, Wang GB, Yang J, Zu Y. Investigation of the change in CD4(+) T cell subset in children with henoch-schönlein purpura. Rheumatol. Int. 32(12), 3785-3792 (2012
94. Jen HY, Chuang YH, Lin SC, Chiang BL, Yang YH. Increased serum interleukin-17 and peripheral Th17 cells in children with acute henoch-schönlein purpura. Pediatr. Allergy Immunol. 22(8), 862-868 (2011).
95. Besbas N, Saatci U, Ruacan S et al. The role of cytokines in henoch-schönlein purpura. Scand. J. Rheumatol. 26(6), 456-460 (1997
96. Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT, Chiang BL. Sera from children with active henoch-schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells. Ann. Rheum. Dis. 63(11), 1511-1513 (2004
97. Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. Nephron 74(1), 79-88 (1996
98. Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL. Thrombopoietin and interleukin-6 levels in henoch-schönlein purpura. J. Microbiol. Immunol. Infect. 39(6), 476-482 (2006
99. Yang YH, Chuang YH, Wang LC, Huang HY, Gershwin ME, Chiang BL. The immunobiology of henoch-schönlein purpura. Autoimmun. Rev. 7(3), 179-184 (2008
100. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 84(7), 2068-2101 (1994
101. Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y. Imbalances in serum proinflammatory cytokines and their soluble receptors: A putative role in the progression of idiopathic IgA nephropathy (IgAN) and henoch-schönlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin. Exp. Immunol. 114(3), 468-476 (1998
102. Wu L, Yuan LP, Fei WJ et al. Impact of sera from children with active henoch-schönlein purpura on human umbilical venous endothelial cells (HUVECs) and protective effects of methylprednisolone against HUVECs injury. Zhongguo Dang Dai Er Ke Za Zhi 14(1), 59-63 (2012
103. Yang YH, Huang YH, Lin YL et al. Circulating IgA from acute stage of childhood henoch-schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway. Clin. Exp. Immunol. 144(2), 247-253 (2006
104. Takemura T, Yoshioka K, Murakami K et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch. 424(5), 459-464 (1994
105. Gattorno M, Vignola S, Barbano G et al. Tumor necrosis factor induced adhesion molecule serum concentrations in henoch-schönlein purpura and pediatric systemic lupus erythematosus. J. Rheumatol. 27(9), 2251-2255 (2000
106. Gok F, Ugur Y, Ozen S, Dagdeviren A. Pathogenesis-related adhesion molecules in henoch-schönlein vasculitis. Rheumatol. Int. 28(4), 313-316 (2008
107. Chen T, Guo ZP, Li MM et al. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of henoch-schönlein purpura. Clin. Exp. Immunol. 166(1), 64-71 (2011
108. Topaloglu R, Sungur A, Baskin E, Besbas N, Saatci U, Bakkaloglu A. Vascular endothelial growth factor in henoch-schönlein purpura. J. Rheumatol. 28(10), 2269-2273 (2001
109. Yao JS, Zhai W, Young WL, Yang GY. Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: The role for KDR and MMP-9. Biochem. Biophys. Res. Commun. 342(4), 1396-1404 (2006
110. Mahajan N, Bisht D, Dhawan V, Singh S, Minz RW. Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in henoch-schönlein purpura. Acta Paediatr. 99(8), 1248-1252 (2010
111. Shin JI, Song KS, Kim H et al. The gene expression profile of matrix metalloproteinases and their inhibitors in children with henoch-schönlein purpura. Br. J. Dermatol. 164(6), 1348-1355 (2011
112. Bertani T, Abbate M, Zoja C et al. Tumor necrosis factor induces glomerular damage in the rabbit. Am. J. Pathol. 134(2), 419-430 (1989
113. Kawasaki Y, Suzuki J, Sakai N et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis. Am. J. Kidney Dis. 44(1), 42-49 (2004
114. Sun DQ, Zhang QY, Dong ZY, Bai F. Levels of IL-12 produced by dendritic cells and changes of TH1/TH2 balance in children with henoch-schönlein purpura. Zhongguo Dang Dai Er Ke Za Zhi 8(4), 307-310 (2006
115. Tahan F, Dursun I, Poyrazoglu H, Gurgoze M, Dusunsel R. The role of chemokines in henoch-schönlein purpura. Rheumatol. Int. 27(10), 955-960 (2007
116. De Mattia D, Penza R, Giordano P et al. von Willebrand factor and factor XIII in children with henoch-schönlein purpura. Pediatr. Nephrol. 9(5), 603-605 (1995
117. Soylemezoglu O, Sultan N, Gursel T, Buyan N, Hasanoglu E. Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in henoch-schönlein purpura. Arch. Dis. Child. 75(6), 507-511 (1996
118. Del Vecchio GC, Penza R, Altomare M et al. Cytokine pattern and endothelium damage markers in henoch-schönlein purpura. Immunopharmacol. Immunotoxicol. 30(3), 623-629 (2008
119. Brendel-Muller K, Hahn A, Schneppenheim R, Santer R. Laboratory signs of activated coagulation are common in henoch-schönlein purpura. Pediatr. Nephrol. 16(12), 1084-1088 (2001
120. Yilmaz D, Kavakli K, Ozkayin N. The elevated markers of hypercoagulability in children with henoch-schönlein purpura. Pediatr. Hematol. Oncol. 22(1), 41-48 (2005
121. Topaloglu R, Bayrakci US, Cil B, Orhon D, Bakkaloglu A. henoch-schönlein purpura with high factor VIII levels and deep venous thrombosis: An association or coincidence? Rheumatol. Int. 28(9), 935-937 (2008
122. Imai T, Okada H, Nanba M, Kawada K, Kusaka T, Itoh S. henoch-schönlein purpura with intracerebral hemorrhage. Brain Dev. 24(2), 115-117 (2002
123. Culic S, Jakl R, Metlicic V et al. Platelet function analysis in children with schönlein-henoch syndrome. Arch. Med. Res. 32(4), 268-272 (2001
124. Knight JF. The rheumatic poison: A survey of some published investigations of the immunopathogenesis of henoch-schonlein purpura. Pediatr. Nephrol. 4(5), 533-541 (1990
125. Harris EN, Gharavi AE, Hughes GR. Anti-phospholipid antibodies. Clin. Rheum. Dis. 11(3), 591-609 (1985
126. Ravelli A, Martini A. Antiphospholipid syndrome. Pediatr. Clin. North Am 52(2), 469-491; vi (2005
127. Matsuura E, Igarashi Y, Fujimoto M et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 148(12), 3885-3891 (1992
128. Sokol DK, Mcintyre JA, Short RA et al. henoch-schönlein purpura and stroke: Antiphosphatidylethanolamine antibody in CSF and serum. Neurology 55(9), 1379-1381 (2000
129. Abend NS, Licht DJ, Spencer CH. Lupus anticoagulant and thrombosis following henoch-schönlein purpura. Pediatr. Neurol. 36(5), 345-347 (2007
130. Shin JI, Lee JS, Kim HS. Lupus anticoagulant and IgM anti-phospholipid antibodies in Korean children with henoch-schönlein purpura. Scand. J. Rheumatol. 38(1), 73-74 (2009
131. Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as complicated henoch- schönlein purpura. Arch. Dis. Child. 86(2), 132-133 (2002
132. Liu A, Zhang H. Detection of antiphospholipid antibody in children with henoch-schönlein purpura and central nervous system involvement. Pediatr. Neurol. 47(3), 167-170 (2012
133. Zhang H, Huang J. henoch-schönlein purpura associated with antiphospholipid syndrome. Pediatr. Nephrol. 25(2), 377-378 (2010
134. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. High titer of serum antiphospholipid antibody levels in adult henoch-schönlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum. 59(4), 561-567 (2008
135. Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ, Chiang BL. Increased transforming growth factor-beta (TGFbeta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood henoch-schönlein purpura. Clin. Exp. Immunol. 122(2), 285-290 (2000
136. Ozaltin F, Bakkaloglu A, Ozen S et al. The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood henoch-schönlein purpura. Clin. Rheumatol. 23(5), 426-429 (2004
137. Sinico RA, Tadros M, Radice A et al. Lack of IgA antineutrophil cytoplasmic antibodies in henoch-schönlein purpura and IgA nephropathy. Clin. Immunol. Immunopathol. 73(1), 19-26 (1994
138. Robson WL, Leung AK, Woodman RC. The absence of anti-neutrophil cytoplasmic antibodies in patients with henoch-schönlein purpura. Pediatr. Nephrol. 8(3), 295-298 (1994
139. Saulsbury FT. Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Schonlein purpura. Arthritis Rheum. 35(11), 1377-1380 (1992
140. Saulsbury FT, Pearl ER. Cold reacting antinuclear antibody in henoch-schönlein purpura. J. Clin. Lab. Immunol. 12(3), 123-127 (1983
141. Mills JA, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of henoch-schönlein purpura. Arthritis Rheum. 33(8), 1114-1121 (1990
142. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 33(8), 1065-1067 (1990
143. Ozen S, Ruperto N, Dillon MJ et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann. Rheum. Dis. 65(7), 936-941 (2006).
144. Ozen S, Pistorio A, Iusan SM et al. EULAR/PRINTO/PRES criteria for henoch-schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann. Rheum. Dis. 69(5), 798-806 (2010
145. Sohagia AB, Gunturu SG, Tong TR, Hertan HI. henoch-schönlein purpura-a case report and review of the literature. Gastroenterol. Res. Pract. 2010, 597648 (2010
146. Kawakami T. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis. J. Dermatol. 37(2), 113-124 (2010
147. Linskey KR, Kroshinsky D, Mihm MC Jr, Hoang MP. Immunoglobulin-A- associated small-vessel vasculitis: A 10-year experience at the Massachusetts General Hospital. J. Am. Acad. Dermatol. 66(5), 813-822 (2012
148. Davin JC, Weening JJ. Diagnosis of henoch-schönlein purpura: Renal or skin biopsy?Pediatr. Nephrol. 18(12), 1201-1203 (2003
149. Van Hale HM, Gibson LE, Schroeter AL. henoch-schönlein vasculitis: Direct immunofluorescence study of uninvolved skin. J. Am. Acad. Dermatol. 15(4 Pt 1), 665-670 (1986
150. Nagasaka T, Miyamoto J, Ishibashi M, Chen KR. MPO-ANCA-and IgA-positive systemic vasculitis: A possibly overlapping syndrome of microscopic polyangiitis and henoch-schönlein purpura. J. Cutan. Pathol. 36(8), 871-877 (2009
151. Watanabe K, Abe H, Mishima T, Ogura G, Suzuki T. Polyangitis overlap syndrome: A fatal case combined with adult henoch-schönlein purpura and polyarteritis nodosa. Pathol. Int. 53(8), 569-573 (2003
152. Akimoto S, Ishikawa O, Tsukada Y, Yano S, Miyachi Y. Microscopic polyangiitis mimicking henoch-schönlein purpura followed by severe renal involvement: A diagnostic role for antineutrophil cytoplasmic autoantibody. Br. J. Dermatol. 136(2), 298-299 (1997
153. Park CK, Ko YH, Park MH, Lee JD, Lee CW. Polyangiitis overlap syndrome: Cutaneous leukocytoclastic vasculitis associated with polyarteritis nodosa. J. Korean Med. Sci. 9(3), 243-247 (1994
154. Yokose T, Aida J, Ito Y, Ogura M, Nakagawa S, Nagai T. A case of pulmonary hemorrhage in henoch-schönlein purpura accompanied by polyarteritis nodosa in an elderly man. Respiration 60(5), 307-310 (1993
155. Shin JI, Lee JS. Multiorgan involvement of vasculitis: Henoch-schönlein purpura alone or polyangiitis overlap syndrome. Kidney Int. 74(6), 828 (2008
156. Leung AK, Robson WL. Hemorrhagic bullous lesions in a child with henoch-schönlein purpura. Pediatr. Dermatol. 23(2), 139-141 (2006
157. Trapani S, Mariotti P, Resti M, Nappini L, De Martino M, Falcini F. Severe hemorrhagic bullous lesions in henoch-schönlein purpura: Three pediatric cases and review of the literature. Rheumatol. Int. 30(10), 1355-1359 (2010
158. Ishii Y, Takizawa T, Arakawa H et al. Hemorrhagic bullous lesions in henoch-schönlein purpura. Pediatr. Int. 47(6), 694-697 (2005
159. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am. J. Clin. Dermatol. 9(2), 71-92 (2008
160. Tizard EJ, Hamilton-Ayres MJ. henoch-schönlein purpura. Arch. Dis. Child. Educ. Pract. Ed. 93(1), 1-8 (2008
161. Tsolia MN, Fretzayas A, Georgouli H et al. Invasive meningococcal disease presenting as henoch-schönlein purpura. Eur. J. Clin. Microbiol. Infect. Dis. 23(10), 776-779 (2004
162. Al-Attrach I, Al-Shibli A, Al-Riyami L, Al-Salam S. Systemic lupus erythematosus with severe nephritis that mimicked henoch-schönlein purpura. Arab. J. Nephrol. Transplant. 4(3), 159-161 (2011
163. Soylu A, Kavukcu S, Uzuner N, Olgac N, Karaman O, Ozer E. Systemic lupus erythematosus presenting with normocomplementemic urticarial vasculitis in a 4-year-old girl. Pediatr. Int. 43(4), 420-422 (2001
164. Saulsbury FT, Hart MH. Crohn's disease presenting with henoch-schönlein purpura. J. Pediatr. Gastroenterol. Nutr. 31(2), 173-175 (2000
165. Cheungpasitporn W, Jirajariyavej T, Howarth CB, Rosen RM. henoch-schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: A case report. J. Med. Case Rep. 5, 364 (2011
166. Chang WL, Yang YH, Lin YT, Chiang BL. Gastrointestinal manifestations in henoch-schönlein purpura: A review of 261 patients. Acta Paediatr. 93(11), 1427-1431 (2004
167. Zhang Y, Huang X. Gastrointestinal involvement in henoch-schönlein purpura. Scand. J. Gastroenterol. 43(9), 1038-1043 (2008
168. Jasic M, Subat-Dezulovic M, Nikolic H, Jonjic N, Manestar K, Dezulovic M. henoch-schönlein purpura complicated by appendicitis, intussusception and ureteritis. Coll. Antropol. 35(1), 197-201 (2011
169. Abebe M, Patnaik A, Miller F et al. Intestinal infarction and portal vein thrombosis in a patient with henoch-schönlein purpura. Case Rep. Rheumatol. 2012, 672959 (2012
170. Miniter U, Bae-Harboe YS, Powers JG, Campbell SM, Goldberg LJ. Fatal henoch-schönlein purpura in an adult related to bowel perforation: Report and review of the literature. Dermatol. Online J. 18(10), 9 (2012
171. Hashimoto A, Matsushita R, Iizuka N et al. henoch-schönlein purpura complicated by perforation of the gallbladder. Rheumatol. Int. 29(4), 441-443 (2009
172. Gow KW, Murphy JJ, 3rd, Blair GK, Magee JF, Hailey J. Multiple entero-entero fistulae: An unusual complication of henoch-schönlein purpura. J. Pediatr. Surg. 31(6), 809-811 (1996
173. Aaron S, Al-Watban L, Manca D. Scrotal involvement in an adult with henoch-schö nlein purpura. Clin. Rheumatol. 32(Suppl. 1), S93-S95 (2013
174. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schö nlein-Henoch syndrome): Review with a follow-up of the renal complications. AM J. Dis. Child 99, 833-854 (1960
175. Chamberlain RS, Greenberg LW. Scrotal involvement in henoch-schö nlein purpura: A case report and review of the literature. Pediatr. Emerg. Care 8(4), 213-215 (1992
176. Silva CA, Cocuzza M, Borba EF, Bonfa E. Cutting-edge issues in autoimmune orchitis. Clin. Rev. Allergy Immunol. 42(2), 256-263 (2012
177. Ha TS, Lee JS. Scrotal involvement in childhood henoch-schönlein purpura. Acta Paediatr. 96(4), 552-555 (2007
178. Iannetti L, Zito R, Bruschi S et al. Recent understanding on diagnosis and management of central nervous system vasculitis in children. Clin. Dev. Immunol. 2012, 698327 (2012
179. Chen CL, Chiou YH, Wu CY, Lai PH, Chung HM. Cerebral vasculitis in henoch-schönlein purpura: A case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatr. Nephrol. 15(3-4), 276-278 (2000
180. Belman AL, Leicher CR, Moshe SL, Mezey AP. Neurologic manifestations of schönlein-henoch purpura: Report of three cases and review of the literature. Pediatrics 75(4), 687-692 (1985
181. Rajagopala S, Shobha V, Devaraj U, D'souza G, Garg I. Pulmonary hemorrhage in henoch-schönlein purpura: Case report and systematic review of the english literature. Semin. Arthritis Rheum. 42(4), 391-400 (2013
182. Markus HS, Clark JV. Pulmonary haemorrhage in henoch-schönlein purpura. Thorax 44(6), 525-526 (1989
183. Paller AS, Kelly K, Sethi R. Pulmonary hemorrhage: An often fatal complication of henoch-schönlein purpura. Pediatr. Dermatol. 14(4), 299-302 (1997
184. Bradley JR, Lockwood CM, Thiru S. Endothelial cell activation in patients with systemic vasculitis. QJM 87(12), 741-745 (1994